Valuation: Medacta Group SA

Market Cap 2.62B 2.92B 2.41B 2.18B 4.08B 278B 4.15B 28.79B 11.49B 146B 10.96B 10.73B 461B P/E 2026 *
27.4x
P/E 2027 * 23x
Enterprise Value 2.86B 3.19B 2.64B 2.39B 4.46B 304B 4.53B 31.46B 12.55B 159B 11.98B 11.72B 504B EV / Sales 2026 *
3.76x
EV / Sales 2027 * 3.34x
Free-Float
29.9%
Yield 2026 *
0.91%
Yield 2027 * 1.04%
1 day+0.50%
1 week+1.51%
Current month+5.95%
1 month+4.85%
3 months-12.19%
6 months-15.38%
Current year-22.63%
1 week 118.2
Extreme 118.2
121.6
1 month 111.2
Extreme 111.2
121.6
Current year 107.4
Extreme 107.4
177.2
1 year 107.4
Extreme 107.4
177.2
3 years 103
Extreme 103
177.2
5 years 76.7
Extreme 76.7
177.2
10 years 39.8
Extreme 39.8
177.2
Manager TitleAgeSince
Chief Executive Officer 49 2018-10-31
Director of Finance/CFO 58 2010-12-31
Investor Relations Contact - 2024-11-20
Director TitleAgeSince
Chairman 82 1998-12-31
Director/Board Member 51 2017-12-31
Director/Board Member 69 2018-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
5/15/26 Sell -219 0.0011%
5/5/26 Buy 1 0.0000%
5/5/26 Buy 1 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.50%+1.51%-17.24%+19.57% 2.92B
+1.88%+2.01%-15.96%+12.62% 181B
+2.55%+1.52%-15.65%+19.03% 120B
+2.46%+0.54%+5.87%+39.87% 119B
+0.36%-1.30%-44.02%+6.28% 91.44B
+1.91%-2.35%-0.79%+76.15% 63.07B
-0.46%+0.42%+8.19%+82.97% 55.8B
+1.63%-1.04%+9.27%-21.17% 54.03B
+2.32%+1.63%-8.23%+47.17% 45.38B
+0.22%+1.59%-1.11%-6.94% 34.37B
Average +1.09%+0.58%-7.97%+27.55% 76.64B
Weighted average by Cap. +1.27%+0.76%-9.97%+26.25%

Financials

2026 *2027 *
Net sales 760M 849M 702M 635M 1.19B 80.85B 1.21B 8.37B 3.34B 42.31B 3.19B 3.12B 134B 858M 958M 792M 717M 1.34B 91.27B 1.36B 9.45B 3.77B 47.77B 3.6B 3.52B 151B
Net income 95.49M 107M 88.1M 79.72M 149M 10.15B 151M 1.05B 419M 5.31B 400M 392M 16.83B 114M 127M 105M 95.07M 178M 12.11B 181M 1.25B 500M 6.34B 477M 467M 20.07B
Net Debt 242M 270M 223M 202M 378M 25.75B 384M 2.67B 1.06B 13.48B 1.01B 993M 42.69B 249M 278M 229M 208M 388M 26.43B 394M 2.74B 1.09B 13.83B 1.04B 1.02B 43.81B
Projected Income Statement - Annual - Medacta Group SA
Logo Medacta Group SA
Medacta Group SA is a Swiss-based company specialized in medical devices. The Company is specialized in the design, production and distribution of orthopedic products and the development of accompanying surgical techniques for joint replacement, spine surgery, and sports medicine. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
Employees
2,273
Date Price Change Volume
26-10-29 CHF 121.00 +1.17% 29,374
26-10-28 CHF 119.60 +0.67% 19,704
26-10-27 CHF 118.80 -1.00% 23,435
26-10-26 CHF 120.00 +1.18% 28,796
26-10-23 CHF 118.60 -0.50% 29,324
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medacta Group SA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
131.16EUR
Average target price
166.55EUR
Spread / Average Target
+26.99%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Medacta Group SA
  1. Stock Market
  2. Stocks
  3. MOVE Stock